National Peroxide Share Price

Natl. Peroxide

CMP as on18-May-22 15:29

₹ 1,537.00
1.95 0.13%

Open

₹ 1,544.45

Turnover (lac)

₹ 55

Prev. Close

₹ 1,535.05

Day's Vol (shares)

₹ 939

Day's Range

₹ 1,521.00
₹ 1,574.90

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 06-May-2022 - -
NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31 2022. NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve Further to our letter dated May 6, 2022, we wish to inform that the Board of Directors at its meeting scheduled on Thursday, May 12, 2022, may consider and recommend dividend, if any, for the financial year ended March 31, 2022. (As per BSE Announcement Dated on 10/5/2022) Further to the letter dated May 6, 2022, National Peroxide Ltd has now informed BSE that the Board of Directors at its meeting scheduled on May 12, 2022, may consider and recommend dividend, if any, for the financial year ended March 31, 2022. (As Per BSE Announcement dated on 11.05.2022) This is to inform you that the Board of Directors at their meeting held today, May 12, 2022, have inter-alia: (1) Approved the Statement of Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2022 and (2) Recommended the final dividend for the financial year ended March 31, 2022 @ 50% i.e., Rs. 5/- (Rupees Five Only) per equity share having face value of Rs. 10/- each to be declared at the Annual General Meeting of the Company. This is to inform you that the Board of Directors at their meeting held today, May 12, 2022 have recommended the final dividend for the financial year ended March 31, 2022 @ 50% i.e., Rs. 5/ (Rupees Five Only) per equity share having face value of Rs. 10/- each to be declared at the Annual General Meeting of the Company. The dividend if declared will be paid / dispatched (subject to deduction / withholding of applicable taxes) within the time prescribed under law. This is to inform you that the Board of Directors at their meeting held today, May 12, 2022 have recommended the final dividend for the financial year ended March 31, 2022 @ 50% i.e., Rs. 5/ (Rupees Five Only) per equity share having face value of Rs. 10/- each to be declared at the Annual General Meeting of the Company. The dividend if declared will be paid / dispatched (subject to deduction / withholding of applicable taxes) within the time prescribed under law. (As Per BSE Announcement dated on 12.05.2022)
Board Meeting - 19-Apr-2022 - -
This is to inform that the Board of Directors of the Company at its Meeting held today i.e., on Tuesday, April 19, 2022 has approved the appointment of CS Heena Shah as Company Secretary and Compliance Officer of the Company and took note of cessation of Mr. Rushabh Ajmera as Interim Compliance Officer w.e.f. April 19, 2022.
Board Meeting - 28-Jan-2022 - -
NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended on December 31 2021. This is to inform you that the Board of Directors at their meeting held today have considered and approved the followings items: i) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2021. ii) Appointment of Mr. Rushabh Ajmera as Interim Compliance Officer of the Company pursuant to Regulation 6(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) with immediate effect. (As Per BSE Announcement dated on 03.02.2022)
Board Meeting - 08-Nov-2021 - -
Quarterly Results This is to inform you that the Board of Directors at its meeting held today considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2021. (As Per BSE Announcement Dated 11.11.2021)
Board Meeting - 05-Aug-2021 - -
Quarterly Results NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021. This is to inform you that the Board of Directors at its meeting held today considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2021. The Unaudited Standalone and Consolidated Financial Results of the Company and the Limited Review Report of the Statutory Auditors on the aforesaid results are also enclosed. (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 24-Jun-2021 - -
National Peroxide Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 29, 2021, inter alia, to:1. consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021; and2. recommend dividend, if any, for the financial year ended March 31, 2021.Further, the trading window as per the Companys Code of Conduct for Prevention of Insider Trading for Designated persons, has been closed from April 01, 2021 till 48 hours after the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending March 31, 2021 are made public. NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve Update on board meeting on recommendation of dividend, if any, for the financial year ended March 31, 2021. (As Per BSE Announcement Dated 24.06.2021) The Board has recommended a Dividend of Rs. 12.50/- (125%) per equity share of face value of Rs. 10/- each for the financial year ended 31st March, 2021, subject to the approval of the Members at the ensuing Annual General Meeting of the Company. 1. Audited Financial Results: The Board has approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended 31st March, 2021. Pursuant to Regulation 33 of the SEBI Listing Regulations, 2015, statements showing Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2021 along with Auditors Report thereon is enclosed herewith for your information and record. 2. Dividend: The Board has recommended a Dividend of Rs. 12.50/- (125%) per equity share of face value of Rs. 10/- each for the financial year ended 31st March, 2021. The Board has approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended 31st March, 2021. Pursuant to Regulation 33 of the SEBI Listing Regulations, 2015, statements showing Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2021 along with Auditors Report thereon is enclosed herewith for your information and record. (As Per BSE Announcement Dated on 29.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity